LifeSignals Achieves EU MDR Certification for UbiqVue 2A Multiparameter System
LifeSignals, Inc. recently announced that its UbiqVue 2A Multiparameter System has earned EU MDR Certification. This certification represents a key development in the ongoing efforts to enhance patient monitoring capabilities in various healthcare settings. With this achievement, the UbiqVue 2A is officially recognized as compliant with EU regulations on medical devices, ensuring both safety and efficacy for users across the health care spectrum.
The UbiqVue 2A Multiparameter System is designed to continuously monitor a range of vital signs, making it a pivotal tool for both home and hospital care environments. Traditional methods often involve manual spot-checking, which can be laborious and subject to human error. The UbiqVue 2A aims to provide a more reliable solution by offering continuous, near real-time monitoring of patients' physiological data. This approach not only simplifies the job of healthcare professionals but also enhances patient care and safety.
At the core of the system is the UbiqVue 2A Biosensor, a user-friendly, single-use wearable device. This innovative device measures key health parameters including SpO2, heart rate, ECG, respiratory rate, body temperature, and more. By securely transmitting encrypted data to a cloud-based platform, healthcare providers can track patients’ vital signs efficiently through an easy-to-use web portal. The system also generates visual alarms and alert notifications, enabling immediate response in critical situations.
“Receiving this Class IIb EU MDR Certification emphasizes our commitment to advancing healthcare technology and providing solutions that enhance patient care,” stated Surendar Magar, Co-founder and CEO of LifeSignals. “We're excited about what this means for the future, not just for individual patient management, but for the broader scope of population health management.”
Furthermore, the UbiqVue System is poised to support scalable healthcare solutions, showcasing LifeSignals' dedication to innovation. The certification follows the recent FDA 510(k) clearance, highlighting the company’s swift progression in regulatory approvals that allow global rollout and partnerships with Original Equipment Manufacturers (OEMs) and service providers.
LifeSignals' UbiqVue system represents a new era in patient monitoring where accessibility and reliability are paramount. By effectively addressing the growing demand for real-time monitoring solutions, the UbiqVue 2A Multiparameter System aligns with the goals of modern healthcare systems aiming to improve overall patient outcomes.
For more information about the UbiqVue system and its benefits, visit
LifeSignals. This groundbreaking technology stands as a significant advancement in the realm of healthcare, paving the way for enhanced patient safety and welfare across both clinical and community environments.